Weight loss intervention

Weight loss intervention has been studied in 12 papers since 2015: 7 trials and 3 observational studies in people, 2 reviews; 5 in the past year. The newest story, Nov 9, 2026: “Type 2 diabetes and obesity linked to faster brain aging”.

Intervention

12 papers study it9 findingsUpdated

1 new paper in 30 daysSee all 12 papers on weight loss intervention

At a glance

The findings reach people, from one lab or study. 6 independent labs in 4 countries.

“the weight-loss intervention did not significantly alter BAG at follow-up (p > 0.05)”
Type 2 Diabetes and Obesity in Relation to Accelerated Brain Aging: Evidence from 12 Cohorts and 2 Randomized Clinical TrialsAHA Scientific Sessions 2026 abstract2026doi:10.1161/circ.154.suppl_1.6410

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 6 independent labs in 4 countries
  • Funders: National Institutes of Health and others
  • Human trial7
  • Humans3

Studies in people

3 studies gave weight loss intervention to people and measured what changed.

What changedDesignPeopleSource

down: Decreases CD36+ extracellular vesicles-1.9-fold

Trial20–24 weeksaged 30 to 60Individuals with obesity and MASLD, individuals with obesity and without MASLD, and lean individuals without MASLDJournal of extracellular vesicles, Mar 1, 2026

no change: Has no effect on transendothelial electrical resistance

Randomized trial72 h29 peopleBothmean age 66.2 ± 7.0 yearsOlder adults; Patient cohortsExperimental physiology, Jan 28, 2026

no change: Has no effect on epigenetic age

Randomized trial6 months333 peoplewomenapproximately 63 years of ageWomenClinical epigenetics, Dec 17, 2021

What did studies of weight loss intervention find?

7

Studies of weight loss intervention measured 7 outcomes, among them CD36+ extracellular vesicles, brain age gap and transendothelial electrical resistance.

CD36+ extracellular vesicles

downin humans1

1 study
  1. Weight loss intervention decreases CD36+ extracellular vesicles in humans (-1.9-fold).

    “We saw similar responses for the CD36+‐EVs (Figure and Table ), with a 1.6‐fold decrease from baseline (9.6 × 106 EVs/mL) to 1 month (4.2 × 106 EVs/mL; β = −0.46; CI: −0.74 to −0.17; p = 0.002) and 1.9‐fold reduction after 5 months (3.3 × 106 EVs/mL; β = −0.65; CI: −0.93 to −0.36; p < 0.001).”

    Human trial20–24 weeks

    Circulating Liver-Derived and CD36⁺ Extracellular Vesicles Correlate With Ectopic Liver Fat and Markers of Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease and Decrease During Weight Loss Intervention

    Journal of extracellular vesicles

  2. Weight loss intervention decreases CD36+ extracellular vesicles in MASLD.

    “During intervention, levels of both ASGR1+-EVs, CD36+-EVs and ASGR1+CD36+-EVs were significantly decreased in the MASLD group already at 1 month and further reduced after 5 months.”

    Human trialin MASLD

    Circulating Liver-Derived and CD36⁺ Extracellular Vesicles Correlate With Ectopic Liver Fat and Markers of Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease and Decrease During Weight Loss Intervention

    Journal of extracellular vesicles

More on CD36+ extracellular vesicles

Brain age gap

no changein humans1

1 study
  1. Weight loss intervention showed no clear effect on brain age gap in humans (Look AHEAD).

    “the weight-loss intervention did not significantly alter BAG at follow-up (p > 0.05)”

    Human trialLook AHEADbrain10-year follow-up

    Type 2 diabetes and obesity linked to faster brain aging

    AHA Scientific Sessions 2026 abstract

More on Brain age gap

Transendothelial electrical resistance

no changein humans1

1 study
  1. Weight loss intervention showed no clear effect on transendothelial electrical resistance in humans.

    “we found no difference in TEER between the CR and CR+WL groups and no significant intervention effects on sEVAT characteristics or TEER”

    Human trial72 hn = 29

    Adipose tissue-derived small extracellular vesicles and blood-brain barrier function in adults with overweight and obesity

    Experimental physiology

More on Transendothelial electrical resistance

Body mass index

downin humans1

1 study
  1. Weight loss intervention decreases body mass index in schizophrenia spectrum disorders with comorbid obesity (p < 0.001).

    “There was a significant reduction in BMI (p < 0.001) between two timepoints.”

    Human trialin schizophrenia spectrum disorders with comorbid obesityn = 48

    The effect of weight loss on brain age in schizophrenia spectrum disorders

    PLOS mental health

More on Body mass index

Cognitive function

downin humans1

1 study
  1. Weight loss intervention impairs cognitive function in humans (type 2 diabetes).

    “The weight loss intervention left a legacy of relatively lower cognitive functioning among women”

    Human trialtype 2 diabetesfemales

    Associations between cognitive function and endogenous levels of estradiol and testosterone in adults with type 2 diabetes

    Journal of diabetes and its complications

Epigenetic age

no changein humans1

1 study
  1. Weight loss intervention showed no clear effect on epigenetic age in humans.

    “In unadjusted intent-to-treat models, when compared to placebo, no treatment arm demonstrated any statistically significant differences or notable trends for any EA marker.”

    Human trial6 monthsn = 192

    An epigenetic aging analysis of randomized metformin and weight loss interventions in overweight postmenopausal breast cancer survivors

    Clinical epigenetics

More on Epigenetic age

Telomere shortening

downin humans1

1 study
  1. Weight loss intervention decreases telomere shortening in humans.

    “significant intervention impacts in delaying telomere shortening, with relatively consistent significant results emerged from weight-loss interventions”

    Review

    The Impact of Health Promotion Interventions on Telomere Length: A Systematic Review

    American journal of health promotion : AJHP

More on Telomere shortening

What is weight loss intervention linked with?

1

Studies link weight loss intervention with body weight.

Body weight

mixedin humans1

1 study
  1. Weight loss intervention is associated with body weight in humans (5% to 20%).

    “response to a weight loss program may range from a weight gain to a greater than expected weight loss”

    Review

    About Unsuccessful Responders to Diet and Physical Activity Interventions: A Focus on Energy Balance and Body-Weight Loss

    Nutrients

Latest

Dec 2025: 0Jan 2026: 2Feb 2026: 0Mar 2026: 1Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 15 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Type 2 diabetes and obesity linked to faster brain aging

Across 12 cohorts, type 2 diabetes was linked to a brain age gap 1.73 years higher than in people without diabetes.Across 12 cohorts, type 2 diabetes was linked to a brain age gap 1.73 years higher than in people without diabetes.

Meta-analysis · 47,994 peopleType 2 diabetes

See all 12 papers on weight loss intervention